Breaking the chains of depression: innovative strategies for treatment, adherence, and well-being

Venkata Nagaraju G; Likhita Gayatri P; Mariyabi SK; Nandini G; Suhana Parveen Patan

doi:10.47957/ijciar.v8i1.195

Authors

G.Venkata Nagaraju Department of Pharmacy Practice, Hindu College of Pharmacy, Guntur, A.P, India.
P.Likhita Gayatri Department of Pharmacy Practice, Hindu College of Pharmacy, Guntur, A.P, India.
SK. Mariyabi Department of Pharmacy Practice, Hindu College of Pharmacy, Guntur, A.P, India.
G. Nandini Department of Pharmacy Practice, Hindu College of Pharmacy, Guntur, A.P, India.
Patan Suhana Parveen Department of Pharmacy Practice, Hindu College of Pharmacy, Guntur, A.P, India.

DOI:

https://doi.org/10.47957/ijciar.v8i1.195

Keywords:

Urolithiasis, Struvite, Ureteroscopy, ESWL, SWL, PCNL, Analgesics

Abstract

Observational studies suggest that there is increasing prevalence rate through worldwide and it has an estimated recurrence risk of 50% probably due to modern life styles and dietary habits. Urolithiasis is a condition of formation of stones (or)caliculi in urinary bladder and or urethra which is characterised by extreme pain in ureter that radiates from flank to the groin or to the genital area and inner thigh. The renal or ureteral stones are of different types based on its mineral composition. The most common stones are struvite, calcium oxalate, urate, cystineand silica. Depending on the type and size of stones physician conclude the type of surgery. An in-depth comprehension regarding urolithiasis is required to provide treatment to the patient. There are several pharmacological and surgical management methods to treat the urolithiasis. Surgical methods include ureteroscopy, SWL (shock wave lithotripsy), ESWL(extracorporeal shockwave lithotripsy), PCNL(percutaneous nephrolithotomy) and Pharmacological treatment includes Analgesics, Alpha-1 adrenergic receptor antagonists.

Downloads

Download data is not yet available.

References

Ara SK. Analysis of the prescribing pattern of antidepressants and the side effects in depression patients. Journal of family medicine and primary care. 2022 Nov 1;11(11):6640-5.

Forbes MP, O’Neil A, Lane M, Agustini B, Myles N, Berk M. Major depressive disorder in older patients as an inflammatory disorder: implications for the pharmacological management of geriatric depression. Drugs & Aging. 2021 Jun;38:451-67. DOI: https://doi.org/10.1007/s40266-021-00858-2

Sandeep Grover SG, Alakananda Dutt AD, Ajit Avasthi AA. An overview of Indian research in depression.

Dadi AF, Miller ER, Bisetegn TA, Mwanri L. Global burden of antenatal depression and its association with adverse birth outcomes: an umbrella review. BMC public health. 2020 Dec;20:1-6. DOI: https://doi.org/10.1186/s12889-020-8293-9

Zhu S, Zhao L, Fan Y, Lv Q, Wu K, Lang X, Li Z, Yi Z, Geng D. Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. Psychoneuroendocrinology. 2020 Apr 1;114:104595. DOI: https://doi.org/10.1016/j.psyneuen.2020.104595

Ara SK. Analysis of the prescribing pattern of antidepressants and the side effects in depression patients. Journal of family medicine and primary care. 2022 Nov 1;11(11):6640-5.

Park LT, Zarate Jr CA. Depression in the primary care setting. New England Journal of Medicine. 2019 Feb 7;380(6):559-68. DOI: https://doi.org/10.1056/NEJMcp1712493

Ara SK. Analysis of the prescribing pattern of antidepressants and the side effects in depression patients. Journal of family medicine and primary care. 2022 Nov 1;11(11):6640-5. DOI: https://doi.org/10.4103/jfmpc.jfmpc_1288_21

Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient preference and adherence. 2012 May 1:369-88. DOI: https://doi.org/10.2147/PPA.S29716

Costello CG, Scott CB. Primary and secondary depression: a review. The Canadian Journal of Psychiatry. 1991 Apr;36(3):210-7. DOI: https://doi.org/10.1177/070674379103600310

Clayton PJ, Lewis CE. The significance of secondary depression. Journal of affective disorders. 1981 Mar 1;3(1):25-35. DOI: https://doi.org/10.1016/0165-0327(81)90016-1

Fallahnia N, Ansari L, Mohammadkhani H, Mousazadeh F, Mohammadi Khah M, Ketabchi G. Oral cancer: Nanoparticles as a new horizon in the diagnosis and phototherapy-based therapies. Nanomedicine Research Journal. 2022 Apr 1;7(2):124-39.

Field T. Postpartum depression effects, risk factors and interventions: a review. Clin Depress. 2017;3(122):1-3. DOI: https://doi.org/10.4172/2572-0791.1000122

Fisch RZ. Masked depression: its interrelations with somatization, hypochondriasis and conversion. The International Journal of Psychiatry in Medicine. 1988 Dec;17(4):367-79. DOI: https://doi.org/10.2190/CR7J-WU5N-HC5X-2JQ5

Kumar BA, Lakshman K, Velmurugan C, Sridhar SM, Gopisetty S. Antidepressant activity of methanolic extract of Amaranthus spinosus. Basic and Clinical Neuroscience. 2014;5(1):11

Stahl SM. Stahl's essential psychopharmacology: neuroscientific basis and practical applications. Cambridge university press; 2021 Sep 16 DOI: https://doi.org/10.1017/9781108975292

Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, Van Rhoads RS. American Psychiatric Association practice guidelines for the treatment of patients with major depressive disorder. Am J Psychiatry. 2010;167(Suppl 10):9-118.

Yadav N, Singh A, Kumar D. Video-based depression detection using support vector machine (SVM). InInternational Conference on Computational Intelligence in Communications and Business Analytics 2022 Jan 7 (pp. 311-325). Cham: Springer International Publishing. DOI: https://doi.org/10.1007/978-3-031-10766-5_25

Done SY. Effect of exercise for depression: systematic review and network meta-analysis. BMJ. 2024;384:e075847. DOI: https://doi.org/10.1136/bmj-2023-075847

Beck JS, Beck AT. Cognitive behavior therapy. New York: Basics and beyond. Guilford Publication. 2011 Dec 17:19-20.

Weissman MM, Markowitz JC, Klerman GL. The guide to interpersonal psychotherapy: updated and expanded edition. Oxford University Press; 2017 Aug 1. DOI: https://doi.org/10.1093/med-psych/9780190662592.003.0001

Shedler J. The efficacy of psychodynamic psychotherapy. American psychologist. 2010 Feb;65(2):98 DOI: https://doi.org/10.1037/a0018378

.Segal Z, Williams M, Teasdale J. Mindfulness-based cognitive therapy for depression. Guilford press; 2012 Oct 18.

Sarris J, Logan AC, Akbaraly TN, Amminger GP, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A. Nutritional medicine as mainstream in psychiatry. The Lancet Psychiatry. 2015 Mar 1;2(3):271-4 DOI: https://doi.org/10.1016/S2215-0366(14)00051-0

Walker MP. The role of sleep in cognition and emotion. Annals of the New York Academy of Sciences. 2009 Mar;1156(1):168-97 DOI: https://doi.org/10.1111/j.1749-6632.2009.04416.x

Nutt DJ, King LA, Phillips LD. Drug harms in the UK: a multicriteria decision analysis. The Lancet. 2010 Nov 6;376(9752):1558-65. DOI: https://doi.org/10.1016/S0140-6736(10)61462-6

Thoits PA. Mechanisms linking social ties and support to physical and mental health. Journal of health and social behavior. 2011 Jun;52(2):145-61. DOI: https://doi.org/10.1177/0022146510395592

Kellner CH, Greenberg RM, Murrough JW, Bryson EO, Briggs MC, Pasculli RM. ECT in treatment-resistant depression. American Journal of Psychiatry. 2012 Dec;169(12):1238-44. DOI: https://doi.org/10.1176/appi.ajp.2012.12050648

George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. American Journal of Psychiatry. 2011 Apr;168(4):356-64. DOI: https://doi.org/10.1176/appi.ajp.2010.10060864

Lam RW, Levitt AJ, Levitan RD, Michalak EE, Cheung AH, Morehouse R, Ramasubbu R, Yatham LN, Tam EM. Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized clinical trial. JAMA psychiatry. 2016 Jan 1;73(1):56-63. DOI: https://doi.org/10.1001/jamapsychiatry.2015.2235

Cramer H, Lauche R, Langhorst J, Dobos G. Yoga for depression: A systematic review and meta‐analysis. Depression and anxiety. 2013 Nov;30(11):1068-83. DOI: https://doi.org/10.1002/da.22166

Nel A, Kagee A. Common mental health problems and antiretroviral therapy adherence. AIDS care. 2011 Nov 1;23(11):1360-5 DOI: https://doi.org/10.1080/09540121.2011.565025

Osterberg L, Blaschke T. Adherence to medication. New England journal of medicine. 2005 Aug 4;353(5):487-97. DOI: https://doi.org/10.1056/NEJMra050100

Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009 Jun 16;119(23):3028-35. DOI: https://doi.org/10.1161/CIRCULATIONAHA.108.768986

Iuga AO, McGuire MJ. Adherence and health care costs. Risk management and healthcare policy. 2014 Feb 20:35-44. DOI: https://doi.org/10.2147/RMHP.S19801

DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of internal medicine. 2000 Jul 24;160(14):2101-7. DOI: https://doi.org/10.1001/archinte.160.14.2101

Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annual review of pharmacology and toxicology. 2012 Feb 10;52(1):275-301. DOI: https://doi.org/10.1146/annurev-pharmtox-011711-113247

American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder . American Psychiatric Association. Am J Psychiatry. 2010;167:1.

Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry. 2005 Jun 1;62(6):617-27. DOI: https://doi.org/10.1001/archpsyc.62.6.617

Malhi GS, Mann JJ. Depression the Lancet, 392 (10161), 2299–2312 [Internet]. 2018 DOI: https://doi.org/10.1016/S0140-6736(18)31948-2

Sansone RA, Sansone LA. Antidepressant adherence: are patients taking their medications?. Innovations in clinical neuroscience. 2012 May;9(5-6)

:Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW. Retraction notice to “Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients”[JAD 136/1-2 (2012) 63–71]. Journal of affective disorders. 2017 Oct 1;220:156. DOI: https://doi.org/10.1016/j.jad.2017.06.032

Chronister J. 11 Social Support, Chronic Illness, and Disability. Understanding the experience of disability: Perspectives from social and rehabilitation psychology. 2019 Apr 30:151.

Morres ID, Hatzigeorgiadis A, Stathi A, Comoutos N, Arpin‐Cribbie C, Krommidas C, Theodorakis Y. Aerobic exercise for adult patients with major depressive disorder in mental health services: A systematic review and meta‐analysis. Depression and anxiety. 2019 Jan;36(1):39-53.. DOI: https://doi.org/10.1002/da.22842

Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. The lancet. 2007 Sep 8;370(9590):851-8. DOI: https://doi.org/10.1016/S0140-6736(07)61415-9

Saarni SI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, Lönnqvist J. Impact of psychiatric disorders on health-related quality of life: general population survey. The British journal of psychiatry. 2007 Apr;190(4):326-32. DOI: https://doi.org/10.1192/bjp.bp.106.025106

Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry. 2005 Jun 1;162(6):1171-8. DOI: https://doi.org/10.1176/appi.ajp.162.6.1171

Angermeyer MC, Holzinger A, Matschinger H, Stengler-Wenzke K. Depression and quality of life: results of a follow-up study. International Journal of Social Psychiatry. 2002 Sep;48(3):189-99 DOI: https://doi.org/10.1177/002076402128783235

Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS medicine. 2013 Nov 5;10(11):e1001547. DOI: https://doi.org/10.1371/journal.pmed.1001547